Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Schnabl

Showing results (151-160 of 258) with videos related to

Pageof 26
Sort By:
Frontiers in Physiology|May 12, 2020
Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use DisorderBei Gao, Atoosa Emami, Rongrong Zhou, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 25, 2015
Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesityPhillipp Hartmann, Caroline T Seebauer, Magdalena Mazagova, et al.
Seminars in Liver Disease|August 24, 2022
Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALDRaquel Carvalho-Gontijo, Cuijuan Han, Lei Zhang, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
Enteric dysbiosis associated with a mouse model of alcoholic liver diseaseArthur W Yan, Derrick E Fouts, Johannes Brandl, et al.
Hepatology Communications|July 24, 2019
Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and FibrosisPeter Stärkel, Bernd Schnabl, Sophie Leclercq, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 20, 2020
The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in miceHuikuan Chu, Lu Jiang, Bei Gao, et al.
Alcoholism, Clinical and Experimental Research|July 7, 2020
Deficiency of Intestinal α1-2-Fucosylation Exacerbates Ethanol-Induced Liver Disease in MiceRongrong Zhou, Cristina Llorente, Jinling Cao, et al.
JCSM Communications|October 23, 2025
Non-Cirrhotic Steatotic Liver Disease is Associated With Impaired Muscle Function: A Cross-Sectional StudyGuillaume Henin, Alexis Goffaux, Salomé Declerck, et al.
Fibrogenesis & Tissue Repair|December 25, 2012
Origin of myofibroblasts in liver fibrosisDavid A Brenner, Tatiana Kisseleva, David Scholten, et al.
Hepatology (Baltimore, Md.)|February 22, 2023
IgY antibodies against cytolysin reduce ethanol-induced liver disease in miceNoemí Cabré, Phillipp Hartmann, Cristina Llorente, et al.
Pageof 26

Showing results (151-160 of 258) with videos related to

Sort By:
Pageof 26
Frontiers in Physiology|May 12, 2020
Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use DisorderBei Gao, Atoosa Emami, Rongrong Zhou, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 25, 2015
Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesityPhillipp Hartmann, Caroline T Seebauer, Magdalena Mazagova, et al.
Seminars in Liver Disease|August 24, 2022
Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALDRaquel Carvalho-Gontijo, Cuijuan Han, Lei Zhang, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
Enteric dysbiosis associated with a mouse model of alcoholic liver diseaseArthur W Yan, Derrick E Fouts, Johannes Brandl, et al.
Hepatology Communications|July 24, 2019
Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and FibrosisPeter Stärkel, Bernd Schnabl, Sophie Leclercq, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 20, 2020
The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in miceHuikuan Chu, Lu Jiang, Bei Gao, et al.
Alcoholism, Clinical and Experimental Research|July 7, 2020
Deficiency of Intestinal α1-2-Fucosylation Exacerbates Ethanol-Induced Liver Disease in MiceRongrong Zhou, Cristina Llorente, Jinling Cao, et al.
JCSM Communications|October 23, 2025
Non-Cirrhotic Steatotic Liver Disease is Associated With Impaired Muscle Function: A Cross-Sectional StudyGuillaume Henin, Alexis Goffaux, Salomé Declerck, et al.
Fibrogenesis & Tissue Repair|December 25, 2012
Origin of myofibroblasts in liver fibrosisDavid A Brenner, Tatiana Kisseleva, David Scholten, et al.
Hepatology (Baltimore, Md.)|February 22, 2023
IgY antibodies against cytolysin reduce ethanol-induced liver disease in miceNoemí Cabré, Phillipp Hartmann, Cristina Llorente, et al.
Pageof 26